结直肠癌类器官-基质生物样本库可对个体化治疗反应进行亚型特异性评估
研究建立30例结直肠癌配对患者来源肿瘤类器官(PDTO)与癌症相关成纤维细胞(CAF)的生物样本库,发现异种移植或与CAF共培养可改善转录组保真度并诱导亚型特异性基质基因表达,共培养功能分析揭示CMS4亚型对吉非替尼和SN-38的治疗抵抗及预后表达特征,化学基因组文库筛选确定MET为基质抵抗的共同靶点。
要点
- 共培养或异种移植可改善PDTO转录组保真度并恢复亚型特异性基质基因表达。
- CMS4亚型在共培养中表现出对吉非替尼和SN-38的特异性治疗抵抗。
- 化学基因组筛选确定MET为患者和治疗依赖的基质抵抗共同靶点。
核心结论
- 结直肠癌表型以可塑性方式编码于癌上皮中,强烈依赖环境背景。
- CAF对于体外忠实呈现分子亚型和治疗反应至关重要。
研究设计与样本
- 建立来自30例患者的配对PDTO与CAF结直肠癌类器官-基质生物样本库。
- 采用环境特异性表型分析、共培养功能分析和化学基因组文库筛选。
主要发现
- 异种移植或与CAF共培养改善转录组保真度并诱导亚型特异性基质基因表达。
- 共培养功能分析暴露CMS4特异性对吉非替尼和SN-38的治疗抵抗及预后表达特征。
- 化学基因组文库筛选鉴定患者和治疗依赖的基质抵抗机制,MET为共同靶点。
- PDTO的结直肠癌亚型记忆独立于特定驱动突变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: In colorectal cancers, the tumor microenvironment plays a key role in prognosis and therapy efficacy. Patient-derived tumor organoids (PDTO) show enormous potential for preclinical testing; however, cultured tumor cells lose important characteristics, including the consensus molecular subtypes (CMS). To better reflect the cellular heterogeneity, we established the colorectal cancer organoid-stroma biobank of matched PDTOs and cancer-associated fibroblasts (CAF) from 30 patients. Context-specific phenotyping showed that xenotransplantation or coculture with CAFs improves the transcriptomic fidelity and instructs subtype-specific stromal gene expression. Furthermore, functional profiling in coculture exposed CMS4-specific therapeutic resistance to gefitinib and SN-38 and prognostic expression signatures. Chemogenomic library screening identified patient- and therapy-dependent mechanisms of stromal resistance including MET as a common target. Our results demonstrate that colorectal cancer phenotypes are encrypted in the cancer epithelium in a plastic fashion that strongly depends on the context. Consequently, CAFs are essential for a faithful representation of molecular subtypes and therapy responses ex vivo. SIGNIFICANCE: Systematic characterization of the organoid-stroma biobank provides a resource for context dependency in colorectal cancer. We demonstrate a colorectal cancer subtype memory of PDTOs that is independent of specific driver mutations. Our data underscore the importance of functional profiling in cocultures for improved preclinical testing and identification of stromal resistance mechanisms. This article is featured in Selected Articles from This Issue, p. 2109.
引用
- Farin HF, Mosa MH, Ndreshkjana B, et al. Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses. Cancer Discov. 2023. PMID: 37489084. doi:10.1158/2159-8290.CD-23-0050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。